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Abstract
The aim of the present study was to assess the prevalence of sarcopenia in women with osteopenia/osteoporosis
with or without fragility fractures.
Patients and methods: 112 ambulatory women with osteopenia/osteporosis were included. Body composition was
determined by DXA. Weight, height, body mass index (BMI), bone mineral density (BMD) of the total skeleton, total
lean mass (LM), appendicular lean mass (ALM) and the index: appendicular lean mass/height² (ALM/h²) were
determined. Grip strength and self-selected gait speed were assessed. Results: Average (X ± SD) results were: age
70.9 ± 8.2 years, BMI: 23.1 ± 3.3 kg/h², total skeleton BMD T-Score:-1.7 ± 0.8, total LM 33.3 ± 3.8 kg, ALM 14.4 ±2.1
kg and ALM/h²: 5.86 ± 0.68 kg/h². Walking speed 0.96±0.21m/s and handgrip: 18.8 ± 4.8 kg. The prevalence of
sarcopenia was: 24.7% (International Working Group criteria). Values for BMI, LM, ALM, ALM/h², gait speed and
hand grip were significantly lower in sarcopenic vs. non-sarcopenic patients. 29 patients, average age: 70.5 ± 8.0
years had osteoporotic fragility fractures (Fx). The prevalence of sarcopenia in the group of patients with Fx was
41.4% vs. 19.3% in the non-Fx patients (n=83) (p<0.018).
Conclusion: The prevalence of sarcopenia in women with osteopenia/osteoporosis was higher compared to that
usually reported in non-selected patients of similar age. Those with bone fractures had a significantly higher
prevalence of sarcopenia compared to the non-fracture patients. The assessment of muscle mass and function in
patients with osteopenia/osteoporosis is recommended.
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Introduction
Sarcopenia, low muscle mass and physical performance, is
important for the general health of the elderly and for the evolution of
some frequent chronic illnesses. Sarcopenia also contributes to
disability, reduced ability to cope with the stress of a major illness, and
to mortality in the elderly. The assessment of its prevalence is of
especial interest. This evaluation has been hindered by the lack of a
uniform definition of the disease. However, there is an agreement that
the evaluation should include assessment of the muscle mass as well as
its function [1-3]. A recent report has studied the prevalence of
sarcopenia in a large number of ambulatory Caucasian subjects over 65
years of age, free of significant comorbidities [4]. In women, prevalence
was 11.8% using the International Working Group criteria (IWG) [1].
The frequency of sarcopenia is higher in patients with chronic diseases
[5] or obesity [6]. On the other hand, there is an increased evidence on
the Bone-Muscle interaction and, therefore, on the relationship of
sarcopenia and osteoporosis [7,8].
The aim of the present study was to assess the prevalence of
sarcopenia in women among patients with osteopenia/osteoporosis
with or without fragility fractures.
Methods
Patients
The results of 112 Caucasian ambulatory women, over 50 years,
coming to our Clinic for the prevention/treatment of osteopenia/
osteoporosis between June 2014 and November 2015, were
retrospectively analyzed and eligible for study inclusion. Patients with
significant co-morbilities that cause secondary sarcopenia – such as
COPD, severe chronic renal disease were not included. All these
patients had a DXA evaluation of the lean mass. Gait speed and grip
strength were also assessed.
All included patients had a BMD T-score below -1 SD, in total
skeleton. Twenty nine patients have had a fragility bone fracture within
the last 5 years in the following locations: vertebral 17 and non-
vertebral 15 (wrist: 10, humerus: 2, pelvis: 2, hip: 1). Three of 29
patients had vertebral and non-vertebral fractures. None of the
fractures were acute (last 4 months) and all were ambulatory at the
time of the study.
Measurements
Body composition was determined by DXA. All measurements were
performed with the same equipment (GE Lunar Prodigy software
version 14.1, Madison, Wi, USA). Quality control was performed daily.
As reported previously, coefficient of variation was 0.5% for BMD,
0.8% for total lean mass and 4.8% for total fat mass [9].
Appendicular lean mass/h² values reported for 54 non-selected
women in Buenos Aires, average age: 71 years old [10] were compared
to values reported by Gould et al [11] for 121 Australian women aged
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70-79, showing similar mean values in both groups: 6.5 ± 0.70 kg/m²
and 6.6 ± 0.76 kg/m² (p.n.s), respectively. Based on the similarity of
these results, we have used in our patients the cut-off values, proposed
by the above mentioned criteria [1].
The studied variables included weight, height, body mass index
(BMI), bone mineral density (BMD) of the total skeleton, total fat
mass, total lean mass and appendicular fat and lean mass (ALM). In
addition, the index for appendicular lean mass (arms+legs)/height²
(ALM/h²) was determined.
Grip strength was measured using a dynamometer (Camry). The
average of two measurements was recorded. Habitual gait speed was
measured in a 5 m walk. Results were considered abnormal when
below: 1 m/s [1].
Diagnostic criteria
The term “sarcopenia” was used when a patient had an appendicular
lean mass below: 5.67 kg/m² and the gait speed below 1 m/s [1].
Statistical Methods
For continuous variables the averages were compared with the
Student t test. Previously normal distribution was verified by the
Shapiro-Wilks test and homogeneity of variance by the Bartlet test. To
compare the proportion of sarcopenia in the patients with and without
bone fractures, the homogeneity test for proportions was used. The Ji-
square test was used to prove the null hypothesis of equality. In all
cases 5% significance level was used.
Results
Average (X ± SD) results for the total population (n=112) were: age
70.9 ± 8.2 years, weight 56.7 ± 8.9 kg, height 157 ± 7 cm, BMI: 23.1 ±
3.3 kg/m², total skeleton BMD T-Score: -1.7 ± 0.8, total fat mass: 21.3 ±
6.7 kg, total lean mass 33.3 ± 3.8 kg, ALM 14.4 ± 2.1 kg, appendicular
fat mass 10.8 ± 3.1 kg, ALM/h²: 5.86 ± 0.68 kg/h², walking speed 0.96 ±
0.21 m/s and handgrip: 18.8 ± 4.8 kg.
The prevalence of sarcopenia considering all patients was 24.7%
(IWG criteria) (A similar result was obtained with the EWGSOP
criteria: 23.9%).
Significant differences in body composition and muscle test between
patients with or without sarcopenia (IWG criteria) were as follows:
BMI (kg/m²) 22.01 ± 3.72 vs. 23.39 ± 3.14 p<0.05, total lean mass(kg)
31.32 ± 4.04 vs. 34.01 ± 3.51 p<0.001, ALM (kg) 12.95 ± 1.91 vs. 14.89
± 1.88 p<0.001, ALM/ h² (kg/m²) 5.16 ± 0.34 vs. 6.09 ± 0.60 p<0.001,
gait speed (m/s) 0.82 ± 0.16 vs. 1.01 ± 0.21 p<0.001 and hand grip (kg)
17.51 ± 3.92 vs. 19.26 ± 5.08 p<0.05. No significant differences were
observed in age, weight, height, total fat and BMD T-score of the total
skeleton.
Osteoporotic fractures
29 patients with average age: 70.8 ± 8.0 years, BMI 24.1 ± 3.9 kg/m²,
BMD T-score -1.7 ± 0.8 had osteoporotic fragility fractures (Fx).
Compared to the 83 patients without Fx, the ALM/h² (5.64 ± 0.69 vs.
5.92 ± 0.66 kg/h² p<0.05) and hand grip (17.55 ± 4.90 vs. 19.27 ± 4.86
kg p<0.05) were significantly lower. Prevalence of sarcopenia was
significantly higher in patients with fractures compared to the non-
fracture group (41.4% vs. 19.3 p<0.018) (Figure 1).
The subgroup of patients with vertebral fractures (n=17) had the
following average ± 1 SD: age 71.7 ± 7.9 years, BMI 25.1 ± 4.1 kg/m²,
BMD T-score -1.7 ± 0.9. Compared to the non-Fx patients, only hand
grip (17.26 ± 4.0% vs. 19.27 ± 4.86 p<0.05) was significantly lower,
while ALM/h² (5.65 ± 0.61) only approached significance (0.05>p<0.1)
Forty seven percent of them were sarcopenic (p<0.014 compared to
non-Fx patients).
Figure 1: Prevalence of sarcopenia in all patients with DXA
determined osteopenia/osteoporosis and in those with or without
osteoporotic fractures. *p<0.018 vs. patients without fractures.
Discussion
Some authors have assessed the prevalence of sarcopenia but the
studies reviewed had wide differences in their methodology [2,12].
Lately, Dam et al [4] have determined the prevalence of sarcopenia on
a large population over 65 years of age, using 3 definitions of
sarcopenia. The IWG diagnosis of Sarcopenia is based on the
assessment of the ALM/h² and the walking speed [1]. The European
Working Group adds the evaluation of hand grip to the above
mentioned parameters [2]. Finally the FNIH definition is based on the
assessment of the ALM/BMI plus walking speed and hand grip [3].
In women, the prevalence of sarcopenia was more than double
compared with the results among men. In the former group, the results
varied from only 2.3% (FNIH) (3) to 11.8% (IWG) [1] and 13.3%
(EWGSOP) [2]. With similar methodologies to the two latter studies,
prevalence among women of Asiatic origin was 7.6% in Korea [13] and
~ 12% in two different studies from China [14,15].
The prevalence of sarcopenia, observed in all patients with DXA
determined osteopenia/osteoporosis of the present study, 24.7%, is
markedly higher than the results previously reported in the general
population [4]. The results also showed that the frequency of
sarcopenia is higher in women with osteopenia/osteoporosis even in
the subgroup of those patients without fragility fractures in their
previous history (19.3%) (Figure 1).
The interest of the present study was also to assess the prevalence of
sarcopenia in patients with fragility fractures and to compare the
results with previously published results after hip or vertebral fractures.
Considering all patients with fragility fractures (vertebral and non-
vertebral n=29) in the present study, the prevalence of sarcopenia was
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41.4%. Compared to the non-fracture group (prevalence of sarcopenia
19.3%), the difference was statistically significant (p<0.018).
Previous studies disclosed that after a hip fracture, the prevalence of
sarcopenia varied from ~ 58% to 68% [16,17] in women and ~ 74% in
one study in men [17]. Thus, the prevalence of sarcopenia in patients
with a hip fracture is probably ~ 4 to 5 times higher than among the
general population.
Two articles [18,19] and the present study have assessed the
prevalence of sarcopenia in women with vertebral fractures. With at
least one vertebral fracture, prevalence varied from ~ 33% (18) to ~
42% [19]. In the latter study, prevalence was markedly higher than in
the control group: 26%. In our study, women with vertebral fractures
had a sarcopenia prevalence of 47.1%, against 19.5% in the non-
fracture group (p<0.014 vs. non-Fx group).
The relation between sarcopenia with osteoporosis and fragility
bone fractures has been examined recently [8,20,21]. Retrospective and
prospective studies have supported its relationship. Several studies
have sought to evaluate muscle mass in patients following a hip
fracture. Lang et al. [22] found decreased muscle, measured in the
Hounsfield unit scale, an indicator of intramuscular fat associated with
increased risk of hip fractures.
In addition, other cross-sectional studies reported a relationship
between lean mass and osteoporotic fractures at any site [23], and
more specifically, that sarcopenic women had 2.7 times higher odds of
having osteoporotic fractures and 2.1 times higher risk of falls than
their non-sarcopenic counterparts [24].
Prospective studies have determined the risk of suffering fragility
fractures in men with sarcopenia independently of BMD [25] and in
patients of both sexes followed during 3.4 years [26]. The concomitant
presence of low BMD and sarcopenia significantly increases the risk
[26,27].
The present study has some limitations: the number of patients with
fragility bone fractures is relatively small and only a small percentage
of patients were obese (3.5%) Based on all the aforementioned studies,
simultaneous evaluation of sarcopenia and osteoporosis is potentially
important to identify patients at higher risk of suffering an
osteoporotic fracture and who need prevention and/or treatment for
both conditions, as recently emphasized by Benkly and Cooper [28].
The herein reported results emphasize the need to evaluate the
presence of sarcopenia also in patients with osteopenia/osteoporosis
with or without osteoporotic fractures, to detect a risk factor for bone
and general health. The results would permit to implement preventive
strategies based on high protein diet, vitamin D administration and
specific physical activity programs.
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